Antibiotics - Cyclic lipopeptides: Nursing pharmacology

Cyclic lipopeptides are a new class of antibiotics used to treat complicated infections caused by gram-positive bacteria like Staphylococcus epidermidis, Staphylococcus haemolyticus, and Staphylococcus aureus, especially the methicillin-resistant type called MRSA, as well as Streptococcus agalactiae, Streptococcus pyogenes, and Enterococcus faecalis.

It is also used in bacteremia caused by Staphylococcus aureus, and infective endocarditis caused by MRSA. Currently, there is only one approved medication in this class, called daptomycin, which is given intravenously or intrathecally.

Once administered, it works by binding to the bacterial membrane and perforating it, creating holes that leak ions, causing rapid depolarization.

This ultimately leads to inhibition of bacterial DNA, RNA, and protein synthesis, which in turn results in bacterial cell death.Common side effects of daptomycin include headache, dizziness, insomnia, and hypo- or hypertension.

Clients might also experience gastrointestinal side effects, such as abdominal pain, nausea, vomiting, and diarrhea. In addition, daptomycin may disrupt the healthy intestinal flora, which can allow certain bacteria like Clostridioides difficile to survive and overgrow within the gastrointestinal tract, rarely but potentially leading to Clostridioides difficile infection or CDI for short.

Other side effects include pain or burning with urination, as well as skin manifestations like rash, itching, and pallor, while some clients may also experience numbness and tingling from peripheral neuropathy.

Other serious side effects include eosinophilic pneumonia, nephrotoxicity, anemia, myopathy and rhabdomyolysis with or without renal failure, and hypersensitivity reactions like angioedema or anaphylaxis.Now, daptomycin should be used with caution during pregnancy and breastfeeding, as well as in children and elderly clients.

Precaution should be taken in clients with eosinophilic pneumonia, as well as in those with gastrointestinal, renal, or muscular disease.

Finally, daptomycin should not be combined with certain medications, such as tobramycin, as it increases the risk of daptomycin toxicity; as well as warfarin, which can lead to increased bleeding; and statins, which can increase the risk of rhabdomyolysis.Okay, let’s say a client with cellulitis is prescribed intravenous daptomycin.

You’ll first perform a focused assessment, including weight, vital signs, and noting the degree of pain, warmth, redness, swelling, and type of exudate.

Then, review your client’s latest laboratory test results, including CBC, liver and renal function tests, ESR, CPK, blood culture, wound culture and sensitivity results, and urinalysis.

Lastly, confirm the correct calculation of medication dose to be administered in mg/kg.Next, explain how this medication can kill the bacteria causing their infection, and ultimately decrease their pain and discomfort.

Then, tell them that you will be infusing the medication once daily. Reassure them by letting them know that you will be monitoring for signs and symptoms of side effects, and instruct them to notify you if they experience symptoms of myopathy or rhabdomyolysis, such as muscle aches, pain, or weakness; symptoms of CDI, like abdominal cramping, diarrhea, or bloody stool; symptoms of peripheral neuropathy, such as numbness or tingling of their extremities; as well as symptoms of eosinophilic pneumonia, including cough and shortness of breath.During treatment, continue to monitor your client’s vital signs and fluid intake and output, as well as their laboratory test results, especially CPK and renal function tests, and urinalysis.

Finally, be sure to watch closely for the development of side effects; and assess their wound for the desired therapeutic effect of infection resolution and decreased inflammation.Alright, as a quick recap… Daptomycin is a cyclic lipopeptide antibiotic used to treat complicated infections caused by multiple gram-positive bacteria, including Methicillin-resistant Staphylococcus aureus, or MRSA, as well as in bacteremia caused by Staphylococcus aureus, and endocarditis caused by MRSA.

Daptomycin works by perforating the bacterial membrane, which ultimately inhibits bacterial DNA, RNA, and protein synthesis, leading to bacterial cell death.

Important side effects include myopathy, rhabdomyolysis, peripheral neuropathy, eosinophilic pneumonia, and an increased risk of CDI.

When caring for a client on daptomycin, nursing considerations include performing a baseline assessment, and monitoring for side effects and the desired therapeutic effect of infection resolution.

Client teaching is focused on the purpose of the medication, as well as learning to recognize side effects that can occur during treatment.

recognize side effects that